Everolimus Inhibits Growth of Gemcitabine-Resistant Pancreatic Cancer Cells via Induction of Caspase-Dependent Apoptosis and G2/M Arrest-Reference-Cited by-同舟云学术

Everolimus Inhibits Growth of Gemcitabine-Resistant Pancreatic Cancer Cells via Induction of Caspase-Dependent Apoptosis and G2/M Arrest

Published:2017-04-25 Issue:9 Volume:118 Page:2722-2730
ISSN:0730-2312
Container-title:Journal of Cellular Biochemistry
language:en
Short-container-title:J. Cell. Biochem.

Author:

Peng Tao¹²,Dou Q. Ping²^ORCID

Affiliation:

1. Pancreatic Disease Institute; Tongji Medical College; Union Hospital; Huazhong University of Science and Technology; Wuhan 430022 P. R. China

2. Departments of Oncology, Pharmacology, and Pathology; Barbara Ann Karmanos Cancer Institute; Wayne State University School of Medicine; Detroit Michigan

Funder

Washington State University

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference25 articles.

1. Chemical inhibitors and microRNAs (miRNA) targeting the mammalian target of rapamycin (mTOR) pathway: Potential for novel anticancer therapeutics;Alqurashi;Int J Mol Sci,2013

2. Kinetic studies on 2′,2′-difluorodeoxycytidine (gemcitabine) with purified human deoxycytidine kinase and cytidine deaminase;Bouffard;Biochem Pharmacol,1993

3. Tyrosine kinase inhibitors in non-small cell lung and pancreatic cancer: The emerging role of erlotinib;Dediu;J BUON,2007

4. Putative roles of retinoblastoma protein in apoptosis;Dou;Apoptosis,1997

5. The role of eIF4 in cell proliferation;Flynn;Cancer Surv,1996

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Roles of Rictor alterations in gastrointestinal tumors (Review);Oncology Reports;2024-01-04

2. Targeting KRAS for the potential treatment of pancreatic ductal adenocarcinoma: Recent advancements provide hope (Review);Oncology Reports;2023-10-04

3. Reshaping the Pancreatic Cancer Microenvironment at Different Stages with Chemotherapy;Cancers;2023-04-25

4. Three generations of mTOR kinase inhibitors in the activation of the apoptosis process in melanoma cells;Journal of Cell Communication and Signaling;2023-04-25

5. Case report: Responses to the combination of gemcitabine with sirolimus in two patients with TSC-mutated sarcomas;Frontiers in Oncology;2023-02-09